Login to Your Account

Milestone makes ready for phase III with $55M series C

By Marie Powers
News Editor

Tuesday, August 1, 2017

Milestone Pharmaceuticals Inc. collected its biggest raise to date, completing a $55 million series C led by Novo Holdings A/S that included new investors Forbion Capital Partners and funds managed by Tekla Capital Management.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription